Subsidies & Funding

We empower medical innovation

Project Management

We manage your EU Horizon 2020 project

Business Strategy

We support successful commercialisation

Funding database

EU & non EU subsidies

News

Top 6 new funding opportunities for SMEs in life sciences and biotechnology

September 01 2016

Bio and medtech companies, developing new drugs and diagnostics, need sufficient funding for their very costly  research and development path. These paths often have a high development risk. Finding these funds to increase the chances for success continues to be a hassle. ttopstart aids such bio and medtech companies in acquiring dilutive (Venture Capital) and non-dilutive capital, such as the highly attractive grants in the life science sector, to become successful.  

Our Life Science Funding Database guides entrepreneurs and academia in identifying and obtaining such grants and gives them time to focus on that what they are really passionate about. 

The latest funding opportunity news:

RVO: innovatiekrediet open from 1-1-2017 till 31-12-2017
marie skodowska curie innovative training networks ETN deadline 10-1-2017
SME instrument: Cell technologies for medical applications deadline 18th of January,
SME instrument: ict solutions for health, well-being and ageing well deadline 18th of January,
h2020: personalised computer models and in-silico systems for well being deadline 14th of March and,
h2020: in-silico trials for developing and assessing biomedical products deadline 14th of March

 


Opportunity

Purpose &
requirements

Funding per project

Funding rate

Deadline

RVO: innovatiekrediet
 

Funding for companies that do not have sufficient funds to finance a complete technical innovation.

Up to € 10 million

50%

1-1-2017 till 31-12-2017


marie skodowska curie innovative training networks ETN

Funding to train a new generation of creative, entrepreneurial and innovative early-stage researchers for current and future challenges.


€ 1 - 3 million

100%

10-1-2017

SME instrument: Cell technologies for medical
applications

Phase II

Funding for activities like clinical validation, upscaling of manufacturing, risk assessment, design or market studies and intellectual property exploration. 

€ 1 - 5 million

100%

18-01-2017
 

SME instrument: ict solutions for health, well-being and ageing well
Phase II

Funding for activities like risk assessment, design or market studies and intellectual property exploration.

€ 1 - 2.5 million

70%

18-01-2017

h2020: personalised computer models and in-silico systems for well being
 

Funding for the development of integrative simulation systems with application in well-being, health and disease. 

€ 4 - 6 million

100%

14-03-2017

h2020: in-silico trials for developing and assessing biomedical products
 

Funding for studies developing and researching in-silico clinical trials (ISCT) to reduce animal and human testing.

€ 4 - 6 million

100%

14-03-2017

 

Check out the Life Science Funding Database for all funding opportunities.

For more information regarding funding opportunities or our business strategy services (after for example a successful SME instrument Phase I application), please contact Neeltje.

 

Share this